IRON earnings: real EPS beat/miss history, analyst consensus Buy, P/E -11.19. Updated 2026-07-23.
Disc Medicine (IRON) Research Hub
Disc Medicine (IRON) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 70.06 USD (-8.43%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -11.19, market cap 2.83B. This hub links to the full technical, earnings and options research available for IRON.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 70.06 USD (-8.43%) |
| 52-week range | 68.18 USD – 83.63 USD |
| Trend regime | Range |
| 14-day RSI | 33.7 (Bearish) |
| Trailing P/E | -11.19 |
| Market cap | 2.83B |
| Dividend yield | 0.00% |
Available research for IRON
Covered Call on IRON: how it works, illustrative setup around the real 70.06 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IRON: how it works, illustrative setup around the real 70.06 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IRON: how it works, illustrative setup around the real 70.06 USD price, max profit/loss, breakeven and when to use it. Educational.
IRON technical analysis: range, last 70.06 USD, RSI 33.7, 52w range 68.18 USD–83.63 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is IRON in?
Disc Medicine (IRON) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is IRON in an uptrend or downtrend?
As of 2026-09-11, IRON is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IRON's trailing P/E ratio?
IRON's trailing P/E is -11.19, with a market cap of 2.83B. See the earnings research page for full valuation detail.